Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kiniksa Pharmaceuticals, Ltd. (KNSA)  
$41.14 0.41 (0.99%) as of 4:30 Tue 12/9


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 40,450,000
Market Cap: 1.66(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.17 - $42.71
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with unmet medical need. Co.'s portfolio of assets include: ARCALYST® (rilonacept) is for the treatment of Cryopyrin-Associated Periodic Syndrome; mavrilimumab is targeting granulocyte-macrophage colony stimulating factor receptor alpha; vixarelimab is evaluating vixarelimab for the potential treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404 is a humanized monoclonal antibody that is designed to inhibit the CD40-CD154 interaction.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 494,439 1,114,088 1,661,320 2,349,338
Total Sell Value $19,067,210 $39,533,094 $53,657,338 $70,061,551
Total People Sold 5 8 8 8
Total Sell Transactions 12 29 63 91
End Date 2025-09-11 2025-06-10 2024-12-10 2023-12-11

   
Records found: 518
  Page 1 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-11-26 4 AS $42.89 $8,578 D/D (200) 22,714 -2%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-11-26 4 OE $22.89 $4,578 D/D 200 22,914     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-11-17 4 AS $40.08 $514,224 D/D (12,470) 22,714 1%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-11-17 4 OE $8.83 $57,395 D/D 6,500 35,184     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-11-13 4 GA $0.00 $0 I/I 60,000 60,000     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-11-13 4 GD $0.00 $0 I/I 60,000 51,794     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2025-11-12 4 AS $40.94 $814,706 D/D (19,900) 31,086 3%     
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2025-11-12 4 OE $30.93 $615,507 D/D 19,900 50,986     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-11-12 4 GA $0.00 $0 I/I 111,794 111,794     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-11-12 4 GD $0.00 $0 D/D 111,794 0     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2025-10-31 4 AS $37.14 $3,065,610 D/D (82,542) 61,324 13%     
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2025-10-31 4 OE $3.80 $545,040 D/D 82,542 143,866     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2025-10-28 4 AS $41.00 $4,100 D/D (100) 31,086 6%     
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2025-10-28 4 OE $30.93 $3,093 D/D 100 31,186     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-10-22 4 AS $38.83 $3,781,654 D/D (97,390) 111,794 7%     
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-10-22 4 OE $3.80 $370,082 D/D 97,390 209,184     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-10-21 4 AS $38.77 $1,524,863 D/D (39,331) 111,794 7%     
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-10-21 4 OE $3.80 $149,458 D/D 39,331 151,125     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-10-20 4 AS $38.81 $4,717,015 D/D (121,248) 111,794 7%     
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-10-20 4 OE $3.80 $460,742 D/D 121,248 233,042     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-10-20 4 AS $38.72 $1,962,781 D/D (50,490) 27,046 7%     
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-10-20 4 OE $10.76 $456,999 D/D 39,435 77,536     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-10-14 4 AS $37.65 $465,843 D/D (12,368) 28,684 10%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-10-14 4 OE $8.83 $57,395 D/D 6,500 41,052     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-10-04 4 D $38.49 $3,272 D/D (85) 38,101     -
  518 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us